Oesophageal Cancer Trial, Recruiting (NCT03712774)

Oesophageal Cancer Trial, Recruiting NCT03712774 Sponsor: Ludwig-Maximilians - University of Munich Condition: Oesophageal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03712774 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Oesophageal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with esophageal cancer (a specific type confirmed by a tissue biopsy), and it has not spread to distant parts of the body (spread to lymph nodes near the collarbone is still acceptable)
You are planned to receive chemotherapy combined with radiation therapy, using one of two specific drug combinations, with the goal of curing the cancer
You are 18 years old or older
You are willing and able to sign a consent form agreeing to take part
You are able to fill out standardised questionnaires, as judged by your treating doctor

Who may not be able to join:

You are under 18 years old
Your treatment is intended to manage symptoms rather than to cure the cancer
Your cancer has spread to distant parts of the body (spread only to lymph nodes near the collarbone is still acceptable)
You have, or have had, another type of cancer
You have already received systemic treatment (such as chemotherapy) for your esophageal cancer
You are currently taking part in another interventional clinical study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Falk Roeder, MD, Ludwig-Maximilians Universität München

Phone: +49 89 4400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03712774

Sponsor: Ludwig-Maximilians - University of Munich

Phase: Not Applicable

Status: Recruiting

Condition: Oesophageal Cancer

Trial contact: +49 89 4400

More information: https://clinicaltrials.gov/study/NCT03712774

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with esophageal cancer (a specific type confirmed by a tissue biopsy), and it has not spread to distant parts of the body (spread to lymph nodes near the collarbone is still acceptable)
You are planned to receive chemotherapy combined with radiation therapy, using one of two specific drug combinations, with the goal of curing the cancer
You are 18 years old or older
You are willing and able to sign a consent form agreeing to take part
You are able to fill out standardised questionnaires, as judged by your treating doctor

Who may not be able to join:

You are under 18 years old
Your treatment is intended to manage symptoms rather than to cure the cancer
Your cancer has spread to distant parts of the body (spread only to lymph nodes near the collarbone is still acceptable)
You have, or have had, another type of cancer
You have already received systemic treatment (such as chemotherapy) for your esophageal cancer
You are currently taking part in another interventional clinical study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ludwig-Maximilians - University of Munich

Registry

ClinicalTrials.gov

Start date

12 October 2018

Est. completion

31 December 2021

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov